In Vivo Distribution of Avidin-Conjugated MX35 and 211At-Labeled, Biotinylated Poly-l-Lysine for Pretargeted Intraperitoneal α-Radioimmunotherapy-Reference-Cited by-同舟云学术

In Vivo Distribution of Avidin-Conjugated MX35 and 211At-Labeled, Biotinylated Poly-l-Lysine for Pretargeted Intraperitoneal α-Radioimmunotherapy

Published:2011-12 Issue:6 Volume:26 Page:727-736
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Frost Sofia Helena Linnea¹,Bäck Tom¹,Chouin Nicolas¹,Jensen Holger²,Hultborn Ragnar³,Jacobsson Lars¹,Lindegren Sture¹

Affiliation:

1. Department of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

2. Cyclotron and PET Unit, Rigshospitalet, Copenhagen, Denmark.

3. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2011.1046

Reference28 articles.

1. Alpha-particles for targeted therapy

2. Therapeutic Radionuclides: Biophysical and Radiobiologic Principles

3. Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals;Chinese Chemical Letters;2022-07

2. Therapeutic Applications of Pretargeting;Pharmaceutics;2019-09-01

3. Avidin-based nanoparticles for drug delivery;Applications of Nanocomposite Materials in Drug Delivery;2018

4. The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis;Journal of Controlled Release;2017-01

5. Sequential Radioimmunotherapy with 177Lu- and 211At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model;Cancer Biotherapy and Radiopharmaceuticals;2014-08